October 2026
1. ABDEL-MONEIM AS, Al-Balushi MS, Al-Jabri AA
   Post-COVID-19 immune dysregulation and autoimmune sequelae.
   Virology. 2026;623:111017.
   

   >> Share

   
   
2. WANG Z, Pan Q, Arduini A, Liang C, et al
   Identification of SARS-CoV-2 proteins suppressing host protein synthesis.
   Virology. 2026;623:111006.
   

   >> Share

   
   
3. DICKERSON A, Cruceanu A, Pokharel BR, Majumdar N, et al
   Deciphering the miR-29c-3p / TET3 regulatory axis within the SARS-CoV-2-infected midbrain.
   Virology. 2026;623:110989.
   

   >> Share

   
   
4. YOSHIDA K, Yamamoto S, Ogasawara N, Taniguchi K, et al
   Innate immune-regulated sulfated glycosaminoglycans are associated with progeny respiratory syncytial virus retention at the cell surface in immortalized cell lines.
   Virology. 2026;623:110974.
   

   >> Share

   
   August 2026
5. BYRNE AMP, James J, Thomas SS, Warren CJ, et al
   Impact of prior low-pathogenicity avian influenza H7N7 exposure on susceptibility and protection against homologous high-pathogenicity avian influenza H7N7 challenge in chickens.
   Virology. 2026;624:111047.
   

   >> Share

   
   
6. KOVACS E, Rios Carrasco M, Guerreiro Cabana MF, de Vries RP, et al
   H5N1 2.3.4.4b HA E190D and Q226H mutations, picked up as minority variants in a patient, result in an inability to bind sialic acid.
   Virology. 2026;621:110949.
   

   >> Share

   
   July 2026
7. KIMURA R, Hayashi Y, Fujimoto-Sato Y, Ishii H, et al
   Decoding viral evolution through integrative bioinformatics: From genomes to global health.
   Virology. 2026;620:110920.
   

   >> Share

   
   
8. SULLIVAN-HILL B, Shahrudin S, Ashley CL, Shields NJ, et al
   SARS-CoV-2 variant-specific enhancement of dendritic heparan sulfate mimetic antiviral activities.
   Virology. 2026;620:110915.
   

   >> Share

   
   
9. LIU C, Yuan X
   Respiratory viruses as key drivers of pulmonary fibrosis: integrated pathways from barrier injury to immune-fibrotic crosstalk.
   Virology. 2026;620:110913.
   

   >> Share

   
   June 2026
10. HEREMIA L, Langsbury H, Treece J, Miller AK, et al
    Rapid GeneXpert surveillance of influenza A virus in seabirds and the environment provides early warning for wildlife health in Aotearoa New Zealand.
    Virology. 2026;623:111014.
    

    >> Share

    
    
11. CHOWDHURY D, Vanderven HA, Wangchuk P, Sarker S, et al
    Mechanistic insights into flavonoid-mediated regulation of human influenza virus replication.
    Virology. 2026;623:111012.
    

    >> Share

    
    
12. MANDVIWALA AS, Liman K, Huckriede ALW, Mishra AC, et al
    Evaluation of MPLA and chimeric TLR agonist adjuvants in RSV virus-like particle vaccines delivered by the intramuscular route.
    Virology. 2026;623:111007.
    

    >> Share

    
    
13. WANG Z, Wongnak R, Oba M, Mizutani T, et al
    Omicron RBD expressed in E. coli outperforms mammalian-expressed S1 spike protein in generating highly neutralizing anti-SARS-CoV-2 antibodies in mice.
    Virology. 2026;619:110894.
    

    >> Share

    
    
14. CHEN G, Liang D, Liu M, Lv Z, et al
    Theaflavins suppresses RSV infection by modulating the MAVS-I-IFN pathway.
    Virology. 2026;619:110872.
    

    >> Share

    
    May 2026
15. UNO N, Ross TM
    Intramuscular administration of influenza hemagglutinin in one hind leg elicits similar protective immune responses as administration in two hind legs.
    Virology. 2026;621:110961.
    

    >> Share

    
    
16. DING K, Ding Y
    H5N1 avian influenza in dairy cattle: Molecular adaptation, transmission mechanisms, and control strategies.
    Virology. 2026;621:110927.
    

    >> Share

    
    
17. ZHANG Y, Liu L, Chen T, Li M, et al
    CD25(+) cell depletion enhances protective immunity of PR8 inactivated influenza vaccine in aged mice.
    Virology. 2026;621:110938.
    

    >> Share

    
    
18. ZHU M, Wang R, Li X, Zhou H, et al
    Canine influenza virus at the human-animal interface: origins, adaptive evolution, and implications for public health.
    Virology. 2026;621:110943.
    

    >> Share

    
    
19. WANG R, Chen J, Zhang H, Qin Y, et al
    Characterization of monoclonal antibody and identification of two novel linear epitopes on the hemagglutinin protein of H3N2 canine influenza virus.
    Virology. 2026;621:110923.
    

    >> Share

    
    April 2026
20. RICHARDSON SAS, Boodhoo N, Bhat S, Wells J, et al
    Differential outcomes of viral co-infections with high pathogenicity avian influenza A(H5N6) and SARS-CoV-2 in mammalian in vitro systems.
    Virology. 2026;620:110912.
    

    >> Share

    
    
21. CALDAS LA, Carneiro FA, Monteiro FLL, Salles TS, et al
    A comparative analysis of virus-cell interactions for two early Brazilian SARS-CoV-2 variants.
    Virology. 2026;617:110822.
    

    >> Share

    
    March 2026
22. RAMUTH M, Sonoo J, Pyndiah N, Rughooputh S, et al
    Epidemiology of influenza A and B viruses in Mauritius over an 8-year period, 2009-2016.
    Virology. 2026;619:110892.
    

    >> Share

    
    
23. LIU R, Patterson L, Yeasmin M, Kim KH, et al
    Low-dose multivalent COVID-19 mRNA vaccines enhance broadly cross-reactive antibodies and protective immune responses of co-administered protein-based vaccines.
    Virology. 2026;619:110884.
    

    >> Share

    
    
24. SWIERKOT J, Tyczynska KM, Siemaszko J, Madej M, et al
    The association of selected genetic polymorphisms with adverse events following COVID-19 vaccination: a single-centre prospective observational cohort study.
    Virology. 2026;619:110876.
    

    >> Share

    
    
25. BARMAN S, Iyengar R, Miller L, Turner JCM, et al
    Reverse genetic rescue and propagation of human influenza A(H3N2) master virus seed in HEK-293 suspension cells.
    Virology. 2026;618:110862.
    

    >> Share

    
    February 2026
26. HAKIM MS, Widyaningsih SA, Ikram A, Goeijenbier M, et al
    Fundamental concepts of convergent (parallel) evolution in human-pathogenic viruses and their implications for global health.
    Virology. 2026;618:110854.
    

    >> Share

    
    
27. LOPEZ-LOPEZ N, Mejia-Torres M, Diaz-Caldera MA, Martinez-Castilla AM, et al
    Sequential infection with rhinovirus followed by Influenza Virus led to an increased antiviral response in A549 cells.
    Virology. 2026;618:110847.
    

    >> Share

    
    
28. POPOVIC ME, Stevanovic M, Tadic V
    COVID-19 ante portas: Empirical formula, growth reactions and thermodynamic properties of biosynthesis and antigen-receptor binding of the Omicron XFG variant of SARS-CoV-2.
    Virology. 2026;614:110742.
    

    >> Share

    
    
29. JEFFREE CE, Lu TB, Tan BH, Sugrue RJ, et al
    Analysis of the surface topology of respiratory syncytial virus particles that form on the surface of virus-infected cells.
    Virology. 2026;614:110732.
    

    >> Share

    
    
30. GARRY RF
    SARS-CoV-2 Spike displays multiple adaptive changes in addition to the furin cleavage site.
    Virology. 2026;614:110720.
    

    >> Share

    
    
31. TERVO S, Zalewski A, Vauhkonen H, Nieoczym M, et al
    Virus circulation in native, introduced, and farmed mustelids in Poland.
    Virology. 2026;615:110771.
    

    >> Share

    
    
32. MILEWSKA A, Konkel R, Hoffmann M, Pohlmann S, et al
    Spumigins produced by Nodularia spumigena are natural serine protease inhibitors with anti-SARS-CoV-2 activity.
    Virology. 2026;615:110763.
    

    >> Share

    
    January 2026
33. ESAKI M, Okuya K, Onuma M, Ozawa M, et al
    Genetically distinct H5N2 high pathogenicity avian influenza virus isolated from a peregrine falcon on Amami-Oshima Island, Japan, harboring enhanced pathogenicity-associated amino acids in the PA protein.
    Virology. 2026;617:110794.
    

    >> Share

    
    
34. IINO Y, Sato K, Furuse Y, Isogai E, et al
    Human parainfluenza virus type 3 viruses with the furin-susceptible motif at the cleavage site of the fusion protein arose from original wild strains during their propagation in vitro.
    Virology. 2026;617:110797.
    

    >> Share

    
    
35. THOMAS MH, Carlock MA, Ross TM
    Adjuvants enhance protective antibodies against seasonal influenza viruses following a single vaccination of Fluzone.
    Virology. 2026;616:110787.
    

    >> Share

    
    
36. JOHNSON MG, Strizki JM, Hilbert DW, Zhang Y, et al
    Impact of baseline humoral immunity on treatment outcomes with molnupiravir in the MOVe-OUT randomized, controlled trial.
    Virology. 2026;613:110710.
    

    >> Share

    
    December 2025
37. NGUYEN CT, Nakayama M, Yasui F, Ishigaki H, et al
    Vaccinia virus-based SARS-CoV-2 vaccine prevents lung immunopathology without antibody-dependent enhancement in female rhesus macaques.
    Virology. 2025;616:110778.
    

    >> Share

    
    November 2025
38. BRICE DC, Andreev K, Miller L, Patton C, et al
    Immunogenicity and efficacy of commercial poultry avian influenza vaccines against HPAI A(H5N1) clade 2.3.4.4b viruses in Mexico.
    Virology. 2025;615:110765.
    

    >> Share

    
    
39. RIVETTI AV JR, Reischak D, Carnegie L, Otaka JNP, et al
    Genomic diversity and reassortment of highly pathogenic avian influenza A/H5N1 virus (clade 2.3.4.4b) in Brazil: Evidence of multiple introductions and intra-epidemic reassortment in 2025.
    Virology. 2025;615:110751.
    

    >> Share

    
    
40. ZHANG X, Guan L, Wang H, Liu J, et al
    Generation and application of novel DNA aptamers targeted to the nucleocapsid protein of the SARS-CoV-2.
    Virology. 2025;612:110688.
    

    >> Share

    
    
41. ZHANG L, Kempf A, Nehlmeier I, Chen N, et al
    Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant.
    Virology. 2025;612:110675.
    

    >> Share

    
    
42. HE Z, Zhang J, Kuang S, Li S, et al
    Colloidal gold technology in viral diagnostics: Recent innovations, clinical applications, and future perspectives.
    Virology. 2025;612:110686.
    

    >> Share

    
    
43. TOBA S, Uemura K, Sanaki T, Kusakabe S, et al
    Synergistic antiviral activity of a cathepsin B/L inhibitor and a TMPRSS2 inhibitor against SARS-CoV-2 in vitro and in vivo.
    Virology. 2025;612:110661.
    

    >> Share

    
    October 2025
44. MELLACE M, Ceniti C, Borrelli L, Tilocca B, et al
    Viral protein mutations enabling mammalian adaptation in Avian Influenza A viruses: Strategies for zoonotic risk mitigation and future perspectives.
    Virology. 2025;614:110731.
    

    >> Share

    
    
45. SEEKINGS AH, Billington E, Mahmood S, Thomas SS, et al
    Infection of point-of-lay hens to assess the sequential events during H7N7 high-pathogenicity avian influenza emergence at a layer premises.
    Virology. 2025;614:110733.
    

    >> Share

    
    
46. WANG A, Hu J, Zhang Q, Zhang Y, et al
    The antiviral activity of interferon-stimulated genes (ISGs) in influenza A virus infection.
    Virology. 2025;614:110728.
    

    >> Share

    
    
47. TSUNEKI-TOKUNAGA A, Komatsu M, Perdana WY, Nishiyama S, et al
    Epidemic influenza virus strains with high growth capability induce severe inflammatory response in vivo.
    Virology. 2025;613:110717.
    

    >> Share

    
    
48. RAVINDRAN C, Mukherjee S
    Zebrafish as a model for SARS-CoV-2 infection, pathogenesis, transmission, and drug screening.
    Virology. 2025;611:110662.
    

    >> Share

    
    
49. LUCINI PAIONI A, Donnici L, Nodari R, Longo Minnolo M, et al
    A rapid and robust luciferase-based reporter system to assess SARS-CoV-2 protease activity.
    Virology. 2025;611:110659.
    

    >> Share

    
    
50. LU CY, Lai PY, Huang JM, Chang LY, et al
    Dual targeting of the Wnt and DNAJB6/MRJ regulatory loop as an anti-RSV strategy.
    Virology. 2025;611:110641.
    

    >> Share

    
    
51. SILVA MO, Daher IP, Oda Ibrahim CH, de Souza EE, et al
    Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants.
    Virology. 2025;611:110629.
    

    >> Share

    
    September 2025
52. SMAOUI F, Taktak A, Gargouri S, Chtourou A, et al
    Impact of the COVID-19 pandemic on the molecular epidemiology of respiratory rhinoviruses and enteroviruses in Tunisia.
    Virology. 2025;610:110624.
    

    >> Share

    
    
53. STEGMANN KM, Dickmanns A, Fuchs HL, Scheibner D, et al
    Synergistic interference with SARS-CoV-2 replication by molnupiravir-derived N(4)-hydroxycytidine and inhibitors of CTP synthetase in cell culture.
    Virology. 2025;610:110598.
    

    >> Share

    
    
54. MOTHAE SA, Chiliza TE, Mvubu NE
    SARS-CoV-2 host-pathogen interactome: insights into more players during pathogenesis.
    Virology. 2025;610:110607.
    

    >> Share

    
    
55. SMET M, Berkell M, Gorska A, Tacconelli E, et al
    Drivers of quasispecies development in SARS-CoV-2 and implications for emergent variants and COVID-19.
    Virology. 2025;610:110584.
    

    >> Share

    
    
56. ZHANG MC, Wu H, Wang J, Lu M, et al
    Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.
    Virology. 2025;610:110579.
    

    >> Share

    
    
57. KIM KH, Hwang HS, Lee Y, Jung YJ, et al
    Interferon-gamma receptor signaling is critical for balanced immune activation and protection against influenza after vaccination.
    Virology. 2025;612:110674.
    

    >> Share

    
    August 2025
58. PAWAR SD, Tare DS, Keng SS, Walimbe AM, et al
    Tracing the possible origins of the clade 2.3.4.4b highly pathogenic avian influenza H5Nx viruses from India.
    Virology. 2025 Aug 29:110654. doi: 10.1016/j.virol.2025.110654.
    

    >> Share

    
    
59. QIAO Y, Tang M, Du M, Zhao C, et al
    H5N1 influenza virus-like particles based on BEVS induce robust functional antibodies and immune responses.
    Virology. 2025;612:110672.
    

    >> Share

    
    
60. CHINNA P, Blumenthal MJ, Lambarey H, Jennings L, et al
    Assessment of gamma-herpesvirus infection dynamics in non-hospitalised people living with HIV during the COVID-19 pandemic in South Africa.
    Virology. 2025;611:110666.
    

    >> Share

    
    
61. BADR C, Arbi M, Souiai O, Larbi I, et al
    Tracing the 2021 equine influenza Outbreak: First characterization and phylogeographic analysis of H3N8 Florida clade 1 virus in Tunisia.
    Virology. 2025;611:110655.
    

    >> Share

    
    July 2025
62. EBRAHIMI N, Sadeh S, Ghaemi A
    Is HA0-Mediated heat resistance in influenza a food safety concern? A methodological critique.
    Virology. 2025 Jul 29:110643. doi: 10.1016/j.virol.2025.110643.
    

    >> Share

    
    
63. CHERNYSHOVA AI, Zhirnov OP
    Influenza A virions with uncleaved hemagglutinin HA0 are more resistant to thermal inactivation than those with cleaved HA1/2: Research and applied significance.
    Virology. 2025 Jul 26:110644. doi: 10.1016/j.virol.2025.110644.
    

    >> Share

    
    
64. FENG X, Yang X, Hu X, Liu Q, et al
    The combinatorial activities of oseltamivir and molnupiravir against influenza virus infections in vitro and in vivo.
    Virology. 2025;611:110642.
    

    >> Share

    
    
65. HU X, Gao M, Ren X, An L, et al
    Effects of synonymous codons with optimization / deoptimization in nucleoprotein (NP) gene of influenza A virus on interaction between NP and tripartite motif protein 25 (TRIM25).
    Virology. 2025;610:110626.
    

    >> Share

    
    
66. LIU R, Song F, Sun L, Yan F, et al
    Exploring the pathogenic and transmission characteristics of JN.1 in golden hamsters based on different attack methods.
    Virology. 2025;608:110548.
    

    >> Share

    
    
67. CAO L, Shi S, Zhang C, Zhao C, et al
    A phycobiliprotein-based reporter assay for the evaluation of SARS-CoV-2 main protease activity.
    Virology. 2025;608:110540.
    

    >> Share

    
    June 2025
68. MEMOLI MJ, Tumpey TM, Jagger BW, Dugan VG, et al
    Corrigendum to: An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice [Virology, volume 393/2 (2009) 539, 338 - 345.
    Virology. 2025 Jun 28:110611. doi: 10.1016/j.virol.2025.110611.
    

    >> Share

    
    
69. PASQUALE S, Moscara L, Palmieri C, Martinelli A, et al
    Safety of SARS-CoV-2 XBB.1.5 and seasonal influenza vaccines co-administration: data from a perspective observational active surveillance study. Puglia (Italy), season 2023/2024.
    Virology. 2025;610:110613.
    

    >> Share

    
    
70. FENG S, Huang M, Quan Y, Sun L, et al
    The spike 486 site is a key immune evasion point and a determinant of the immunogenicity of the RBD-dimer mRNA vaccine against SARS-CoV-2 variants.
    Virology. 2025;610:110612.
    

    >> Share

    
    
71. NGUYEN XD, Le B, Yang Q, Wang B, et al
    PathoSift Pro: A novel size-based bioaerosol sampler for effectively detecting infectious airborne influenza virus.
    Virology. 2025;610:110609.
    

    >> Share

    
    
72. BRUNO A, de Mora D, Olmedo M, Garces J, et al
    Highly pathogenic avian influenza A (H5N1) virus outbreaks in South America in 2022-2024: a comprehensive review of an ongoing panzootic.
    Virology. 2025;610:110602.
    

    >> Share

    
    
73. TABYNOV K, Kuanyshbek A, Zharmambet K, Yelchibayeva L, et al
    Evaluation of commercial vaccines for efficacy and transmission control against the emergent H5N8 (clade 2.3.4.4b) avian influenza virus in Kazakhstan.
    Virology. 2025;610:110601.
    

    >> Share

    
    
74. CHAKRABORTY C, Bhattacharya M, Abdelhameed AS
    Recent SARS-CoV-2 evolution trajectories indicate the emergence of Omicron's several subvariants and the current rise of KP.3.1.1 and XEC.
    Virology. 2025;607:110508.
    

    >> Share

    
    
75. ANDERSON M, Lopez J, Wyr M, Ramirez PW, et al
    Defining diverse spike-receptor interactions involved in SARS-CoV-2 entry: Mechanisms and therapeutic opportunities.
    Virology. 2025;607:110507.
    

    >> Share

    
    
76. BEAUDOIN-BUSSIERES G, Tauzin A, Dionne K, El Ferri O, et al
    Multiple exposures to SARS-CoV-2 Spike enhance cross-reactive antibody-dependent cellular cytotoxicity against SARS-CoV-1.
    Virology. 2025;607:110512.
    

    >> Share

    
    May 2025
77. LENDE SSF, Rothemejer FH, Andreas M, Pedersen ML, et al
    Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis.
    Virology. 2025;610:110573.
    

    >> Share

    
    
78. ISHIGAKI H, Itoh Y
    Translational research on pandemic virus infection using nonhuman primate models.
    Virology. 2025;606:110511.
    

    >> Share

    
    
79. DAS SARMA J
    Murine beta-coronavirus spike protein: A major determinant of neuropathogenic properties.
    Virology. 2025;606:110499.
    

    >> Share

    
    
80. LUNDRIGAN E, Uguccioni S, Hum C, Ahmed N, et al
    SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways.
    Virology. 2025;606:110493.
    

    >> Share

    
    April 2025
81. REUSS D, Brown JC, Sukhova K, Furnon W, et al
    Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epithelium.
    Virology. 2025;608:110556.
    

    >> Share

    
    March 2025
82. RAHA JR, Kim KH, Tien Le CT, Bhatnagar N, et al
    A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e.
    Virology. 2025;606:110510.
    

    >> Share

    
    
83. BANGA NDZOUBOUKOU JL, Kamara AA, Ullah N, Lei Q, et al
    A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults.
    Virology. 2025;606:110509.
    

    >> Share

    
    
84. OSPINA-JIMENEZ AF, Gomez AP, Rincon-Monroy MA, Perez DR, et al
    A novel reassorted swine H3N2 influenza virus demonstrates an undetected human-to-swine spillover in Latin America and highlights zoonotic risks.
    Virology. 2025;606:110483.
    

    >> Share

    
    
85. PAWAR SD, Keng SS, Tare DS, Balakrishnan A, et al
    Evidence of novel reassortment in clade 2.3.4.4b avian influenza H5N1 viruses, India, 2024.
    Virology. 2025;606:110482.
    

    >> Share

    
    
86. LAI SK, Lee ZQ, Tan TI, Tan BH, et al
    Evidence that the cell glycocalyx envelops respiratory syncytial virus (RSV) particles that form on the surface of RSV-infected human airway cells.
    Virology. 2025;604:110415.
    

    >> Share

    
    
87. HILLS FR, Geoghegan JL, Bostina M
    Architects of infection: A structural overview of SARS-related coronavirus spike glycoproteins.
    Virology. 2025;604:110383.
    

    >> Share

    
    
88. PORTER SM, Hartwig AE, Quilici M, Bosco-Lauth AM, et al
    Intraspecific SARS-CoV-2 Delta variant transmission among red fox (Vulpes vulpes) and striped skunk (Mephitis mephitis).
    Virology. 2025;604:110446.
    

    >> Share

    
    
89. HE M, He CQ, Ding NZ
    Human viruses: An ever-increasing list.
    Virology. 2025;604:110445.
    

    >> Share

    
    
90. SHI H, Inankur B, Yin J
    Serum starvation impacts rhinovirus spread from cell to cell.
    Virology. 2025;604:110408.
    

    >> Share

    
    
91. SUGRUE RJ, Tan BH
    The link between respiratory syncytial virus (RSV) morphogenesis and virus transmission: Towards a paradigm for understanding RSV transmission in the upper airway.
    Virology. 2025;604:110413.
    

    >> Share

    
    
92. YAMAMOTO A, Ito H, Sakaguchi T, Higashiura A, et al
    Structural insights into nucleocapsid protein variability: Implications for PJ34 efficacy against SARS-CoV-2.
    Virology. 2025;604:110411.
    

    >> Share

    
    February 2025
93. BENLARBI M, Kenfack DD, Dionne K, Cote-Chenette M, et al
    Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.
    Virology. 2025;605:110467.
    

    >> Share

    
    
94. HARADA R, Hiono T, Igarashi M, Kobayashi D, et al
    Altered receptor-binding specificity of gull-adapted H13 avian influenza viruses corresponds to their unique host preferences.
    Virology. 2025;605:110460.
    

    >> Share

    
    
95. MILLER JL, Niewiesk S
    Review of impaired immune parameters in RSV infections in the elderly.
    Virology. 2025;603:110395.
    

    >> Share

    
    
96. JONES LR
    Intra-host variability of SARS-CoV-2: Patterns, causes and impact on COVID-19.
    Virology. 2025;603:110366.
    

    >> Share

    
    
97. ROY K, Saikia BK, Konwar R
    Exploring the role of carbon quantum dots as countermeasure for SARS-CoV-2 virus.
    Virology. 2025;603:110339.
    

    >> Share

    
    
98. POPOVIC ME, Tadic V, Popovic M
    (R)evolution of Viruses: Introduction to biothermodynamics of viruses.
    Virology. 2025;603:110319.
    

    >> Share

    
    January 2025
99. FRAGOSO-SAAVEDRA M, Liu Q
    Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies.
    Virology. 2025;604:110412.
    

    >> Share

    
    
100. PATEL H, Kukol A
     Harnessing viral internal proteins to combat flu and beyond.
     Virology. 2025;604:110414.
     

     >> Share

     
     
101. HASSAN MSH, Sharif S
     Immune responses to avian influenza viruses in chickens.
     Virology. 2025;603:110405.
     

     >> Share

     
     
102. NI M, Lin S, Shao Y, Tang J, et al
     Enteric pathogenicity characterization of emerging parainfluenza virus 5 in western China.
     Virology. 2025;604:110409.
     

     >> Share

     
     
103. ZHAO Y, Li W, Xu L, Tao Z, et al
     Antibody responses in omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2.
     Virology. 2025;603:110404.
     

     >> Share

     
     
104. SAHA A, Choudhary S, Walia P, Kumar P, et al
     Transformative approaches in SARS-CoV-2 management: Vaccines, therapeutics and future direction.
     Virology. 2025;604:110394.
     

     >> Share

     
     
105. LV X, Zheng T, Lei X, Ren L, et al
     RTP4 restricts influenza A virus infection by targeting the viral NS1 protein.
     Virology. 2025;603:110397.
     

     >> Share

     
     
106. ZHIRNOV OP, Chernyshova AI
     The uncleaved viral hemagglutinin HA0 increases influenza A virus resistance to thermal pasteurization.
     Virology. 2025;604:110389.
     

     >> Share

     
     
107. SULTANA R, Stahelin RV
     Strengths and limitations of SARS-CoV-2 virus-like particle systems.
     Virology. 2025;601:110285.
     

     >> Share

     
     December 2024
108. CALDERON-PEREZ B, Nunez-Munoz LA, Trejo-Ayala LL, Rosales-Garcia VH, et al
     Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-cov-2 and its variants.
     Virology. 2024;603:110380.
     

     >> Share

     
     
109. MCKENNA S, Jung KI, Wolf JJ, Seo YJ, et al
     Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication.
     Virology. 2024;603:110367.
     

     >> Share

     
     
110. OO A, Chen Z, Cao D, Cho YJ, et al
     Biochemical simulation of mutation synthesis and repair during SARS-CoV-2 RNA polymerization.
     Virology. 2024;600:110255.
     

     >> Share

     
     
111. NOWAK R, Gazecka M, Hoffmann M, Kierzek R, et al
     TMPRSS2-specific antisense oligonucleotides inhibit host cell entry of emerging viruses.
     Virology. 2024;600:110218.
     

     >> Share

     
     
112. WANG C, Zhang Y, Yang C, Ren W, et al
     Receptor binding mechanism and immune evasion capacity of SARS-CoV-2 BQ.1.1 lineage.
     Virology. 2024;600:110241.
     

     >> Share

     
     
113. WANG M, Valadez-Ingersoll M, Gilmore TD
     Control of nuclear localization of the nucleocapsid protein of SARS-CoV-2.
     Virology. 2024;600:110232.
     

     >> Share

     
     November 2024
114. YANG S, Yang X, Zhu W, Luo C, et al
     The novel COVID-19 treatment VV116 is a potential inhibitor of Zika virus.
     Virology. 2024;603:110334.
     

     >> Share

     
     
115. KEGEL NB, Kaufmann A, Matrosovich M, Bauer S, et al
     Decomposition of L-glutamine and accumulation of ammonium in cell culture media inhibit infectivity of influenza viruses.
     Virology. 2024;602:110314.
     

     >> Share

     
     
116. ZHAO Q, Zhang J, Yang S, Bai X, et al
     H1N1 swine influenza viruses upregulate NEU1 expression through histone H3 acetylation regulated by HDAC2.
     Virology. 2024;601:110305.
     

     >> Share

     
     October 2024
117. WU Y, Lai SK, En-Zuo Chan C, Tan BH, et al
     Evidence that the SARS-CoV-2 S protein undergoes a conformational change at the Golgi complex that leads to the formation of virus neutralising antibody binding epitopes in the S1 protein subunit.
     Virology. 2024;598:110187.
     

     >> Share

     
     September 2024
118. LIU J, Chen K, Wu W, Pang Z, et al
     GRP78 exerts antiviral function against influenza A virus infection by activating the IFN/JAK-STAT signaling.
     Virology. 2024;600:110249.
     

     >> Share

     
     
119. CHAKRABORTY C, Bhattacharya M
     Evolution and mutational landscape of highly pathogenic avian influenza strain A(H5N1) in the current outbreak in the USA and global landscape.
     Virology. 2024;600:110246.
     

     >> Share

     
     
120. BENITO AA, Monteagudo LV, Lazaro-Gaspar S, Mazas-Cabetas L, et al
     Detection and subtyping of influenza A virus in porcine clinical samples from Spain in 2020.
     Virology. 2024;600:110223.
     

     >> Share

     
     
121. ROOT JJ, Porter SM, Lenoch JB, Ellis JW, et al
     Susceptibilities and viral shedding of peridomestic wildlife infected with clade 2.3.4.4b highly pathogenic avian influenza virus (H5N1).
     Virology. 2024;600:110231.
     

     >> Share

     
     
122. LEI Y, Xu N, Niu C, Chen L, et al
     Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection.
     Virology. 2024;597:110142.
     

     >> Share

     
     
123. LIANG Z, Wang J, Zhang H, Gao L, et al
     Peptide S4 is an entry inhibitor of SARS-CoV-2 infection.
     Virology. 2024;597:110149.
     

     >> Share

     
     
124. DUDEK I, Czerkies M, Kwiatek A
     Differential expression of cytokines and elevated levels of MALAT1 - Long non-coding RNA in response to non-structural proteins of human respiratory syncytial virus.
     Virology. 2024;597:110127.
     

     >> Share

     
     August 2024
125. RZYMSKI P, Niedziela J, Poniedzialek B, Rosinska J, et al
     Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes.
     Virology. 2024;596:110118.
     

     >> Share

     
     July 2024
126. MANDVIWALA AS, Huckriede ALW, Arankalle VA, Patil HP, et al
     Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice.
     Virology. 2024;598:110194.
     

     >> Share

     
     
127. CAI M, Wei Z, Hu X, Ji Y, et al
     The evolution, complexity, and diversity of swine influenza viruses in China: A hidden public health threat.
     Virology. 2024;598:110167.
     

     >> Share

     
     
128. LIU J, Ren T, Wang X, Wang H, et al
     The emergence, isolation, and phylogenetic analysis of a closely related human strain of parainfluenza virus 5 from a case of porcine reproductive and respiratory syndrome in China.
     Virology. 2024;597:110157.
     

     >> Share

     
     
129. LEE J, Naoe Y, Bang U, Nakagama Y, et al
     Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera.
     Virology. 2024;595:110067.
     

     >> Share

     
     
130. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
     Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
     Virology. 2024;595:110082.
     

     >> Share

     
     
131. UENO S, Amarbayasgalan S, Sugiura Y, Takahashi T, et al
     Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
     Virology. 2024;595:110068.
     

     >> Share

     
     June 2024
132. ZHU H, Li X, Li X, Chen H, et al
     Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide.
     Virology. 2024;597:110162.
     

     >> Share

     
     
133. NAVEED A, Yu J, Lawson S, Gao R, et al
     Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli.
     Virology. 2024;597:110138.
     

     >> Share

     
     
134. NGUYEN CT, Nakayama M, Ishigaki H, Kitagawa Y, et al
     Increased expression of CD38 on endothelial cells in SARS-CoV-2 infection in cynomolgus macaques.
     Virology. 2024;594:110052.
     

     >> Share

     
     
135. GE P, Ross TM
     COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
     Virology. 2024;597:110119.
     

     >> Share

     
     May 2024
136. DUCATEZ MF, Wang C, Yang J, Zhao Y, et al
     Infection dynamics of subtype H9N2 low pathogenic avian influenza a virus in turkeys.
     Virology. 2024;596:110124.
     

     >> Share

     
     
137. TIAN Y, Deng Z, Chuai Z, Li C, et al
     A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.
     Virology. 2024;596:110125.
     

     >> Share

     
     
138. BROGAARD L, Heegaard PMH, Larsen LE, Skovgaard K, et al
     Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
     Virology. 2024;596:110117.
     

     >> Share

     
     
139. HUANG J, Ma K, Zhang J, Zhou J, et al
     Pathogenicity and transmission of novel highly pathogenic H7N2 variants originating from H7N9 avian influenza viruses in chickens.
     Virology. 2024;597:110121.
     

     >> Share

     
     
140. SAIKIA BK, Roy K, Konwar R
     Preliminary report on therapeutic potential of coal-derived carbon quantum dots against SARS-CoV-2 virus.
     Virology. 2024;593:110036.
     

     >> Share

     
     
141. LIU J, Gao L, Zhou N, Jiang Z, et al
     p53 suppresses the inflammatory response following respiratory syncytial virus infection by inhibiting TLR2.
     Virology. 2024;593:110018.
     

     >> Share

     
     April 2024
142. MA X, Wang Q, Xu X, Zhang W, et al
     miR-214-PTEN pathway is a potential mechanism for stress-induced immunosuppression affecting chicken immune response to avian influenza virus vaccine.
     Virology. 2024;595:110094.
     

     >> Share

     
     
143. KIM KH, Bhatnagar N, Subbiah J, Liu R, et al
     Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
     Virology. 2024;595:110097.
     

     >> Share

     
     
144. VALLERIANI F, Di Pancrazio C, Spedicato M, Di Teodoro G, et al
     A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice.
     Virology. 2024;592:109997.
     

     >> Share

     
     
145. ALTINA NH, Maranon DG, Anderson JR, Donaldson MK, et al
     The leader RNA of SARS-CoV-2 sequesters polypyrimidine tract binding protein (PTBP1) and influences pre-mRNA splicing in infected cells.
     Virology. 2024;592:109986.
     

     >> Share

     
     March 2024
146. BRIGGS K, Chrzastek K, Segovia K, Mo J, et al
     Genetic insertion of mouse Myxovirus-resistance gene 1 increases innate resistance against both high and low pathogenic avian influenza virus by significantly decreasing replication in chicken DF1 cell line.
     Virology. 2024;595:110066.
     

     >> Share

     
     
147. SAKA N, Nishio M, Ohta K
     Human parainfluenza virus type 2 V protein inhibits mitochondrial apoptosis pathway through two ways.
     Virology. 2024;594:110053.
     

     >> Share

     
     
148. ZHENG X, Yang R, Zhao Y, Zhang Y, et al
     Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
     Virology. 2024;594:110050.
     

     >> Share

     
     
149. HUONG TN, Lee ZQ, Lai SK, Lee HY, et al
     Evidence that an interaction between the respiratory syncytial virus F and G proteins at the distal ends of virus filaments mediates efficient multiple cycle infection.
     Virology. 2024;591:109985.
     

     >> Share

     
     February 2024
150. HUANG Y, Zhang P, Han S, Hu B, et al
     Effect of Enteromorpha polysaccharides on gut-lung axis in mice infected with H5N1 influenza virus.
     Virology. 2024;593:110031.
     

     >> Share

     
     
151. MA B, Tao M, Li Z, Zheng Q, et al
     Mucosal vaccines for viral diseases: Status and prospects.
     Virology. 2024;593:110026.
     

     >> Share

     
     
152. YANG J, Lan R, Chang H, Li H, et al
     Isolation and characterization of genotype 4 Eurasian avian-like H1N1 influenza virus in pigs suffering from pneumonia.
     Virology. 2024;592:110009.
     

     >> Share

     
     
153. LEE DW, Kim JM, Kim DW, Kim JY, et al
     Three distinct ORF1a recombinants of the SARS-CoV-2 Delta variant of concern.
     Virology. 2024;590:109945.
     

     >> Share

     
     January 2024
154. FANG K, Song W, Zhang Y, Zheng Y, et al
     Comparative analysis and prediction of avian influenza in Shangrao city, China from 2016 to 2022.
     Virology. 2024;592:109995.
     

     >> Share

     
     
155. YUAN F, Yang L, Hsiao SH, Herndon NL, et al
     A neonatal piglet model reveals interactions between nasal microbiota and influenza A virus pathogenesis.
     Virology. 2024;592:109996.
     

     >> Share

     
     
156. ZHANG Y, Wang D, Xiang Q, Hu X, et al
     A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein.
     Virology. 2024;589:109925.
     

     >> Share

     
     December 2023
157. TANG C, Carrera Montoya J, Fritzlar S, Flavel M, et al
     Polyphenol rich sugarcane extract (PRSE) has potential antiviral activity against influenza A virus in vitro.
     Virology. 2023;590:109969.
     

     >> Share

     
     
158. BIALY D, Richardson S, Chrzastek K, Bhat S, et al
     Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo.
     Virology. 2023;590:109954.
     

     >> Share

     
     November 2023
159. RAMEY AM, Scott LC, Ahlstrom CA, Buck EJ, et al
     Molecular detection and characterization of highly pathogenic H5N1 clade 2.3.4.4b avian influenza viruses among hunter-harvested wild birds provides evidence for three independent introductions into Alaska.
     Virology. 2023;589:109938.
     

     >> Share

     
     
160. ZHU M, Zeng H, He J, Zhu Y, et al
     Reassortant H9N2 canine influenza viruses containing the pandemic H1N1/2009 ribonucleoprotein complex circulating in pigs acquired enhanced virulence in mice.
     Virology. 2023;589:109927.
     

     >> Share

     
     
161. NAIQING X, Tang X, Wang X, Cai M, et al
     Hemagglutinin affects replication, stability and airborne transmission of the H9N2 subtype avian influenza virus.
     Virology. 2023;589:109926.
     

     >> Share

     
     October 2023
162. AFRIN SZ, Sathi FA, Nooruzzaman M, Parvin R, et al
     Molecular insights into the SARS-CoV-2 Omicron variant from Bangladesh suggest diverse and continuous evolution.
     Virology. 2023;587:109882.
     

     >> Share

     
     
163. KIM IH, No JS, Kim JA, Park AK, et al
     Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023.
     Virology. 2023;587:109869.
     

     >> Share

     
     
164. KNANY HR, Elsabbagh SA, Shehata MA, Eldehna WM, et al
     In silico screening of SARS-CoV2 helicase using African natural products: Docking and molecular dynamics approaches.
     Virology. 2023;587:109863.
     

     >> Share

     
     
165. SHIAU AL, Lee KH, Cho HY, Chuang TH, et al
     Molnupiravir, a ribonucleoside antiviral prodrug against SARS-CoV-2, alters the voltage-gated sodium current and causes adverse events.
     Virology. 2023;587:109865.
     

     >> Share

     
     
166. PONDE RAA
     Physicochemical effects of emerging exchanges on the spike protein's RBM of the SARS-CoV-2 Omicron subvariants BA.1-BA.5 and its influence on the biological properties and attributes developed by these subvariants.
     Virology. 2023;587:109850.
     

     >> Share

     
     
167. ORTEGA GRANDA O, Alvarez K, Mate-Perez MJ, Canard B, et al
     Macro1 domain residue F156: A hallmark of SARS-CoV-2 de-MARylation specificity.
     Virology. 2023;587:109845.
     

     >> Share

     
     September 2023
168. BRIGGS K, Sweeney R, Blehert DS, Spackman E, et al
     SARS-CoV-2 utilization of ACE2 from different bat species allows for virus entry and replication in vitro.
     Virology. 2023;586:122-129.
     

     >> Share

     
     
169. RAMIREZ KA, Mond J, Papenburg J, Boivin G, et al
     In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections.
     Virology. 2023;586:115-121.
     

     >> Share

     
     
170. XIAO Y, Wang L, Fang SS, Luo F, et al
     Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo.
     Virology. 2023;586:105-114.
     

     >> Share

     
     August 2023
171. TEWARI DN, Biswas A, Chakrabarti AK, Dutta S, et al
     AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in response to influenza virus infection in A549 cells.
     Virology. 2023;587:109875.
     

     >> Share

     
     
172. UPRETY T, Sreenivasan CC, Thomas M, Hause B, et al
     Prevalence and characterization of seven-segmented influenza viruses in bovine respiratory disease complex.
     Virology. 2023;587:109859.
     

     >> Share

     
     
173. YOUK S, Torchetti MK, Lantz K, Lenoch JB, et al
     H5N1 highly pathogenic avian influenza clade 2.3.4.4b in wild and domestic birds: Introductions into the United States and reassortments, December 2021-April 2022.
     Virology. 2023;587:109860.
     

     >> Share

     
     
174. MARANO JM, Cereghino C, Finkielstein CV, Weger-Lucarelli J, et al
     An in vitro workflow to create and modify infectious clones using replication cycle reaction.
     Virology. 2023;585:109-116.
     

     >> Share

     
     
175. SILVA JUNIOR JVJ, Duraes-Carvalho R, de Souza JR, Ramos Janini LM, et al
     Emergence of SARS-CoV-2 serotype(s): Is it a matter of time?
     Virology. 2023;585:78-81.
     

     >> Share

     
     July 2023
176. ZHOU H, Liu J, Li L, Sun J, et al
     Circulation of influenza C virus of C/Sao Paulo/378/82 lineage among pediatric acute respiratory cases, Shandong, China.
     Virology. 2023;587:109855.
     

     >> Share

     
     June 2023
177. TANG L, Liu X, Wang C, Shu C, et al
     USP18 promotes innate immune responses and apoptosis in influenza A virus-infected A549 cells via cGAS-STING pathway.
     Virology. 2023;585:240-247.
     

     >> Share

     
     
178. SU R, Shi Z, Li E, Zhu M, et al
     A Trim-RBD-GEM vaccine candidate protects mice from SARS-CoV-2.
     Virology. 2023;585:145-154.
     

     >> Share

     
     
179. YILMAZ B, Cakmak Genc G, Karakas Celik S, Piskin N, et al
     The 3'UTR region of the DNA repair gene PARP-1 May increase the severity of COVID-19 by altering the binding of antiviral miRNAs.
     Virology. 2023;583:29-35.
     

     >> Share

     
     
180. POTTAGE T, Onianwa O, Atkinson B, Spencer A, et al
     Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature.
     Virology. 2023;583:27-28.
     

     >> Share

     
     
181. PFANZAGL B
     The ICAM-1 ligand HRV-A89 is internalized independently of clathrin-mediated endocytosis and its capsid reaches late endosomes.
     Virology. 2023;583:45-51.
     

     >> Share

     
     May 2023
182. CHENCHULA S, Amerneni KC, Ghanta MK, Padmavathi R, et al
     Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review.
     Virology. 2023;584:38-43.
     

     >> Share

     
     
183. SUN X, Belser JA, Kieran TJ, Brock N, et al
     Enhanced fitness of SARS-CoV-2 B.1.617.2 Delta variant in ferrets.
     Virology. 2023;582:57-61.
     

     >> Share

     
     
184. MAYER AM, Grohs Ferrareze PA, de Oliveira LFV, Gregianini TS, et al
     Genomic characterization and molecular evolution of SARS-CoV-2 in Rio Grande do Sul State, Brazil.
     Virology. 2023;582:1-11.
     

     >> Share

     
     April 2023
185. BOSCO-LAUTH A, Rodriguez A, Maison RM, Porter SM, et al
     H7N9 influenza A virus transmission in a multispecies barnyard model.
     Virology. 2023;582:100-105.
     

     >> Share

     
     
186. KANDWAL S, Fayne D
     Genetic conservation across SARS-CoV-2 non-structural proteins - Insights into possible targets for treatment of future viral outbreaks.
     Virology. 2023;581:97-115.
     

     >> Share

     
     March 2023
187. HUONG TN, Ravi Iyer L, Lui J, Wang Y, et al
     The respiratory syncytial virus SH protein is incorporated into infectious virus particles that form on virus-infected cells.
     Virology. 2023;580:28-40.
     

     >> Share

     
     October 2022
188. LAMICHHANE P, Schmidt ME, Terhuja M, Varga SM, et al
     A live single-cycle RSV vaccine expressing prefusion F protein.
     Virology. 2022;577:51-64.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share